Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Thrombectomy Devices Market to Witness Growth at a CAGR of ~5% by 2030 | DelveInsight

This image opens in the lightbox

News provided by

DelveInsight Business Research, LLP

04 Jun, 2024, 09:30 GMT

Share this article

Share toX

Share this article

Share toX

The rise in lifestyle-related conditions like low blood pressure, diabetes, obesity, and aging, along with the growing incidence of venous thromboembolism, cardiovascular diseases, cancer, and neurological disorders such as ischemic stroke, hemorrhagic stroke, and peripheral diseases, is driving up the need for thrombectomy devices.

LAS VEGAS, June 4, 2024 /PRNewswire/ -- DelveInsight's Thrombectomy Devices Market Insights report provides the current and forecast market analysis, individual leading thrombectomy devices companies' market shares, challenges, thrombectomy devices market drivers, barriers, trends, and key market thrombectomy devices companies in the market.

Key Takeaways from the Thrombectomy Devices Market Report

  • As per DelveInsight estimates, North America is anticipated to dominate the global thrombectomy devices market during the forecast period. 
  • In the product segment of the thrombectomy devices market, the mechanical thrombectomy category had a significant revenue share in the year 2023. This can be ascribed to the applications and advantages related to the segment.
  • Notable thrombectomy devices companies such as Koninklijke Philips N.V., Terumo Corporation, Medtronic, Boston Scientific Corporation, Penumbra, Inc., Thrombolex, Imperative Care Inc., Stryker, Argon Medical Devices Inc., Edwards Lifesciences Corporation, Johnson & Johnson, BD, phenox GmbH, DSMAREF CO.LTD, Teleflex Incorporated, AngioDynamics, Abbott, inari Medical, Merit Medical Systems, Acandis GmbH, and several others, are currently operating in the thrombectomy devices market.
  • In September 2022, Vesalio announced European CE Mark approval of the company's NeVa Net thrombectomy device, which features integrated clot microfiltration technology.
  • In September 2021, Abbott acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots. Walk Vascular's peripheral thrombectomy systems will be incorporated into Abbott's existing endovascular product portfolio.
  • In May 2020, Control Medical Technology obtained the US Food and Drug Administration (FDA) approval for its Aspire MAX 7 – 11F Mechanical Thrombectomy platform. Aspire MAX 7 – 11F Mechanical Thrombectomy platform has been designed to remove blood clots from the peripheral vessels.

To read more about the latest highlights related to the thrombectomy devices market, get a snapshot of the key highlights entailed in the Global Thrombectomy Devices Market Report

Thrombectomy Devices Overview

Thrombectomy devices represent a groundbreaking advancement in the field of interventional medicine, offering a minimally invasive solution for treating stroke and other vascular occlusions. These devices are engineered to swiftly and effectively remove blood clots from arteries, restoring blood flow to the affected area and mitigating the risk of debilitating neurological damage. Utilizing innovative techniques such as aspiration and stent retrievers, thrombectomy devices enable clinicians to rapidly intervene in acute ischemic stroke cases, significantly improving patient outcomes and reducing long-term disability.

The evolution of thrombectomy devices has revolutionized stroke care, extending the therapeutic window for treatment and expanding access to critical interventions. With enhanced maneuverability and imaging guidance, these devices empower clinicians to navigate complex vascular anatomy precisely, optimizing outcomes for patients facing life-threatening thrombotic events. As ongoing research continues to refine these technologies and broaden their applicability, thrombectomy devices stand as a beacon of hope in the fight against stroke, offering a transformative approach to restoring neurological function and preserving the quality of life.

Thrombectomy Devices Market Insights

In 2023, North America led the thrombectomy devices market due to various factors. These include the region's high prevalence of conditions like cancer, neurological disorders, cardiovascular diseases, and venous thromboembolism. Moreover, the growing elderly population susceptible to these ailments, rising obesity rates, early adoption of advanced technologies, robust healthcare infrastructure, increased investments from both governmental and private sectors, and a surge in regulatory approvals are all contributing to a positive growth outlook for the North American market.

For example, the CDC's 2023 data reveals that around 33% of individuals in the US experiencing deep vein thrombosis or pulmonary embolism are likely to have a recurrence within a decade. Additionally, the CDC's 2021 report highlights that over 795,000 Americans suffer from strokes annually, with the majority being first-time occurrences, predominantly ischemic strokes where brain blood flow is obstructed.

These statistics underscore the escalating prevalence of cardiovascular and neurological disorders in the region, thereby bolstering the demand for thrombectomy devices crucial for managing or treating these conditions. Furthermore, the continuous influx of regulatory approvals and product launches, such as Stryker Neurovascular's FDA approval for Trevo NXT Pro Vue Retriever in August 2021 and February 2020, is propelling market growth. These strategic advancements are instrumental in augmenting the demand for thrombectomy devices, thus propelling the North American thrombectomy devices market during the projected period.

To know more about why North America is leading the market growth in the thrombectomy devices market, get a snapshot of the Thrombectomy Devices Market Outlook 

Thrombectomy Devices Market Dynamics

The thrombectomy devices market is experiencing significant dynamics driven by a multitude of factors including technological advancements, increasing prevalence of cardiovascular diseases, and growing awareness about minimally invasive surgical procedures. Thrombectomy devices are primarily used to remove blood clots from arteries or veins, thereby restoring blood flow and preventing potentially life-threatening conditions such as stroke or pulmonary embolism. With the aging population and rising incidences of obesity and sedentary lifestyles, the demand for these devices is on the rise.

One of the key dynamics shaping the thrombectomy devices market is the continuous innovation in device design and technology. Manufacturers are investing heavily in research and development to introduce advanced thrombectomy devices that offer improved efficacy, safety, and patient outcomes. This includes the development of devices with better navigation capabilities, enhanced suction power, and compatibility with various anatomical structures.

Moreover, there is a growing trend towards the adoption of minimally invasive procedures over traditional surgical methods. Thrombectomy devices play a crucial role in this shift as they enable physicians to remove blood clots with minimal trauma to surrounding tissues, reduced risk of complications, and faster recovery times for patients. As a result, healthcare providers are increasingly incorporating thrombectomy procedures into their treatment protocols, driving the demand for these devices.

Another significant factor influencing the thrombectomy devices market dynamics is the increasing incidence of cardiovascular diseases worldwide. Conditions such as ischemic stroke, acute myocardial infarction, and deep vein thrombosis are becoming more prevalent, creating a substantial patient pool in need of thrombectomy interventions. Additionally, the rise in awareness about the importance of early detection and treatment of such conditions is fueling the demand for thrombectomy devices among both healthcare providers and patients.

Furthermore, the thrombectomy devices market is witnessing consolidation activities as major players seek to strengthen their market presence through strategic partnerships, mergers, and acquisitions. This consolidation is aimed at expanding product portfolios, leveraging complementary technologies, and gaining access to new geographic markets. As a result, the competitive landscape of the thrombectomy devices market is evolving rapidly, with companies vying for market share through innovation, differentiation, and market expansion strategies. Overall, these dynamics are expected to continue driving growth in the thrombectomy devices market in the coming years.

Get a sneak peek at the thrombectomy devices market dynamics @ Thrombectomy Devices Market Dynamics Analysis

Report Metrics

Details

Coverage

Global

Study Period

2021–2030

Thrombectomy Devices Market CAGR

~5%

Key Thrombectomy Devices Companies

Koninklijke Philips N.V., Terumo Corporation, Medtronic, Boston Scientific Corporation, Penumbra, Inc., Thrombolex, Imperative Care Inc., Stryker, Argon Medical Devices Inc., Edwards Lifesciences Corporation, Johnson & Johnson, BD, phenox GmbH, DSMAREF CO.LTD, Teleflex Incorporated, AngioDynamics, Abbott, inari Medical, Merit Medical Systems, Acandis GmbH, among others

Thrombectomy Devices Market Assessment

  • Thrombectomy Devices Market Segmentation
    • Thrombectomy Devices Market Segmentation By Product: Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Ultrasonic Thrombectomy Devices, and Others
    • Thrombectomy Devices Market Segmentation By Application: Cardiovascular Thrombectomy, Neurovascular Thrombectomy, and Peripheral Vascular Thrombectomy
    • Thrombectomy Devices Market Segmentation By End User: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
    • Thrombectomy Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
  • Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Which MedTech key players in the thrombectomy devices market are set to emerge as the trendsetter explore @ Thrombectomy Devices Companies 

Table of Contents 

1

Report Introduction

2

Executive summary

3

Regulatory and Patent Analysis

4

Key Factors Analysis

5

Porter's Five Forces Analysis

6

Thrombectomy Devices Market Layout

7

Global Company Share Analysis – Key 3-5 Companies

8

Thrombectomy Devices Market Company and Product Profiles

9

Project Approach

10

About DelveInsight

Interested in knowing the thrombectomy devices market by 2030? Click to get a snapshot of the Thrombectomy Devices Market Trends

Related Reports

Ischemic Stroke Pipeline

Ischemic Stroke Pipeline Insight – 2024 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key Ischemic Stroke companies, including Athersys, Inc., Tarveda Therapeutics, Lumosa Therapeutics, NC Medial Research Inc, Acticor Biotech, Meridigen Biotech Co., Prolong Pharmaceuticals, Nanjing Yoko Biomedical Co., Ltd., TrueBinding, Inc., GNT Pharma, Roche, DiaMedica Therapeutics Inc, aptaTargets, Bristol-Myers Squibb, NuvOX Pharma, Simcere Pharmaceutical Co., Ltd., Genentech, Inc., NoNO Inc., Pharming Technologies B.V., Biogen, Avilex Pharma, SanBio, ZZ Biotech, Revalesio, Stemedica Cell Technologies, StemCyte, Ninnion, Algernon Pharmaceuticals, Primary Peptides, TMS, Tasly Pharmaceutical, Pharmazz, among others.

Ischemic Stroke Epidemiology

Ischemic Stroke Epidemiology Forecast – 2032 report delivers an in-depth understanding of the disease, historical, and forecasted ischemic stroke epidemiology in the 7MM.

Acute Ischemic Stroke Market

Acute Ischemic Stroke Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key acute ischemic stroke companies, including Acticor Biotech, DiaMedica Therapeutics, Lumosa Therapeutics, Bristol Myers Squibb, Janssen Pharmaceutical, Genentech, Inc., Athersy, Healios K.K., NoNO Inc., Bayer, ZZ Biotech, Biogen Inc., Revalesio Corporation, AbbVie, TrueBinding, Inc, Silver Creek Pharmaceuticals, among others.

Acute Ischemic Stroke Pipeline

Acute Ischemic Stroke Pipeline Insight – 2024 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key acute ischemic stroke companies, including Genentech, Acticor Biotech, DiaMedica Therapeutics, and NoNO, among others.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. 

Contact Us
Shruti Thakur
info@delveinsight.com
+14699457679
https://www.delveinsight.com/medical-devices

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg

Modal title

Also from this source

Sleep Apnea Market to Accelerate Substantially at a CAGR of 20% During the Study Period (2020-2034) | DelveInsight

Sleep Apnea Market to Accelerate Substantially at a CAGR of 20% During the Study Period (2020-2034) | DelveInsight

DelveInsight's Sleep Apnea Market Insights report includes a comprehensive understanding of current treatment practices, sleep apnea emerging drugs,...

NADPH Oxidase (NOX)-Replacement Therapies Market to Observe Stunning Growth During the Forecast Period (2025-2034) Across 7MM | DelveInsight

NADPH Oxidase (NOX)-Replacement Therapies Market to Observe Stunning Growth During the Forecast Period (2025-2034) Across 7MM | DelveInsight

DelveInsight's NADPH Oxidase (NOX)-Replacement Therapies Market Size, Target Population, Competitive Landscape & Market Forecast report includes a...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

Medical Equipment

Medical Equipment

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.